ANTI-PD1Intervention1 paperHumans1LatestScience Translational Medicine·10 SepInterferon-induced senescent CD8⁺ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancerCohort study of 171 peopleBlood and immune systemPaper
Science Translational Medicine·10 SepInterferon-induced senescent CD8⁺ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancerCohort study of 171 peopleBlood and immune systemPaper